Three Pieces of Legislation

15 July 2026

Legend

Transcript markers

  • text Sentence being played
  • text Search result
  • text Intervention cited by the link you opened

Click a sentence to play the video from that moment. Select text to quote it with the speaker, timestamp and link.

More options
Official source
Offset

Transcript offset

0s
Text size
Export

Select segments to export (Word)

0 segments selected

House Energy and Commerce Subcommittee on Health U.S. House of Representatives

Follow its sittings
15:20 - 17:25
Speaker 1
Subcommittee will come to order.  The chair recognizes himself for an opening statement.  Today's markup will focus on a few bills that work to combat the illicit drug crisis facing our communities, specifically targeting the growing threat posed by pill presses.  These bills work together to create a regulatory framework that allows DEA to conduct oversight of a closed system of distribution for pill presses and their critical parts, just like we have for controlled substances.  This system ensures good actors are able to utilize pill presses for legitimate intended uses, while giving DEA the tools to monitor suspicious orders and prevent bad actors from diverting pill presses for the illicit production of counterfeit pills. 

HR 5880, the Fight Illicit Pill Presses Act, is led by Representative Hageman from Wyoming and would establish requirements for serial numbers, record keeping, and transaction reporting for pill presses and their critical parts.  The Preventing Rogue Equipment for Synthetic Substances Act, PRESS Act, HR 7184, is led by Representative McDow from North Carolina.  It would criminalize the importation of pill press equipment with the intent to illicitly produce a controlled substance.  HR 8005, the Stop Pills That Kill Act, is led by Representative Evans from Colorado.  This legislation would apply enhanced criminal penalties to those who engage in the illicit manufacture of fentanyl, fentanyl analogues, or fentanyl-related substances. 

It would also direct the DEA to establish and implement a comprehensive plan to address the threat of counterfeit pills that contain fentanyl, methamphetamine, or any other illicit synthetic substance.  I look forward to continuing the work on these policies and bringing them to the full committee.  I now recognize the ranking member Ms. DeGette for her five-minute opening statement. 
17:25 - 20:55
Speaker 5
Thank you so much, Mr. Chairman.  You know, we all want to curb the spread of dangerous illicit drugs, but I'm concerned that these bills fall short of meaningfully improving law enforcement efforts and could further our nation's addiction to criminalization.  At best, I think these bills need work.  I think we need to better consider practical concerns, and at the worst, I think these bills just make illegal conduct more illegal.  I'm not sure the bills will help. 

So I want to talk briefly about something that I think would work, and that's bipartisan common-sense legislation that Congresswoman Miller-Meeks and I introduced yesterday.  The Cure Hepatitis C Act paves the way for our country to eliminate hepatitis C as a major health threat.  It's a gem of an opportunity to lower costs and save lives.  Highly effective antiviral treatments for this debilitating disease have been around since 2013, and they cure more than 95% of cases without significant side effects.  But even so, over four million people in the US now have hepatitis C. 

Left untreated, this disease leads to a lifetime of chronic health issues and even death.  Development of a cure was one of the most remarkable medical achievements of our lifetime, but still, more than a decade after initial approval, tens of thousands of Americans die of hepatitis C every year.  That's because people with the disease don't always feel sick and know they're infected, which complicates diagnosis.  And because the affected population is so disproportionately underserved already, sometimes they're in prison, for example, they're not consistently engaged with the healthcare system.  The cost of antiviral therapies is also cost-prohibitive for many, and a standard regimen can cost tens of thousands of dollars if you don't have insurance. 

This bill would close these access gaps and put life-saving therapeutics in the hands of those who need it by taking a pilot program that was pioneered by Louisiana nationwide, allowing states to partner with manufacturers to tailor treatment to different priority populations.  And so in short, when we pass this bill, it will save thousands of lives.  It'll also save money in the healthcare system by reducing spending on chronic disease management, which can include expensive treatments for cirrhosis, liver cancer, and liver transplantation.  A preliminary CBO estimate of this policy found, for example, it would save $6.6 billion.  I'm so happy to have worked on this bill with my colleague and our committee member from Iowa, and also Representatives Hank Johnson and Don Bacon, as well as our Senate counterpart, Senators Cassidy and Van Hollen. 

Each of us is committed to passing this groundbreaking bill by the end of the year for a variety of reasons, but mostly because we need to start saving lives right now.  Mr. Chairman, I'm sorry to hijack this opening statement, but we're going to need the full force of this subcommittee to pass this bill.  And I think really the solution is before us, lives are on the line, and we don't have a minute to delay.  And so I'm looking forward to working with you, Ms. Miller-Meeks, and everybody else, and the chairman and ranking member to make sure we get this done, and I yield back. 
20:55 - 21:05
Speaker 1
Gentleman yields back, and I look forward to reading the bill that was introduced yesterday, and now recognize the gentleman from Kentucky, the chairman of the full committee, Mr. Guthrie, for five minutes for an opening statement. 
21:06 - 21:33
Speaker 4
Good morning, everyone, and thank you, Chairman, for the recognition and holding this important markup.  Today we're continuing the committee's work to combat the threat of existing and emerging drug threats by advancing legislation that will help to keep illicit drugs out of our communities.  In 2025, DEA seized more than 47 million counterfeit pills containing fentanyl.  Just two milligrams of fentanyl is considered a potentially lethal dose.  That's small enough to fit on the tip of a pencil. 

21:34 - 22:33

Brett Guthrie

Now bad actors are using punches and dies and imitate the markings of legitimate prescriptions like oxycodone, Xanax, and Adderall to manufacture counterfeit pills in illicit tabs. Over 98% of the pills seized and tested by the DEA had fake pharmaceutical imprints. But these counterfeits are widely available due to criminal drug networks and are being falsely marketed as legitimate prescription pills to deceive the American public. The bills before us today take important steps to safeguard public health by equipping all law enforcement officials with the necessary resources to protect Americans from the threat posed by deadly counterfeit pills. I appreciate the work that has gone into these bills already, and I look forward to continuing the process.

Thank you, Mr. Chairman, and I yield back.

22:33 - 25:47

Frank Pallone

Thank you, and the gentleman yields back, and now recognize the ranking member of the full committee, the gentleman from New Jersey, Mr. Pallone, for his five minutes for an opening statement.

Thank you, Chairman Griffith. Today we're marking up three bills to address the supply chains that turn illicit chemicals into counterfeit pills. They target the equipment, the importation, and the production behind the fentanyl crisis. H.R. 5880, the Fight Illicit Pill Presses Act, requires people to identify tableting and encapsulating machines by serial number so that when the law enforcement seizes a press, they can trace it. The bill mirrors the Biden administration's Detect and Defeat Counter-Fentanyl proposal, which called on Congress to establish a nationwide pill press and tableting machine registry so officials could track these machines and their illicit use.

And while I support the intent of this bill, I do have some concerns that it will tag unwitting individuals with criminal liability. There may be people who are not intending or are not aware that a pill press will be used for an illicit use. Then there's H.R. 2184, the PRESS Act, would make it unlawful to manufacture, distribute, or import pill press equipment with the intent to illicitly produce a controlled substance.

And then H.R. 8005, the Stop Pills That Kill Act, implements sentencing penalties for producing fentanyl, fentanyl analogues, or counterfeit pills, and it requires the DEA to create a comprehensive plan to address counterfeit substances. Now, we share jurisdiction over these bills with our colleagues on the House Judiciary Committee, and I hope we can work together to ensure that we fully understand the real implications of the criminal penalty component to all these bills. After all, we've made real progress over the last several years in strong bipartisan fashion to combat the overdose crisis, but an enforcement-only strategy is not the answer, particularly at a time when the administration's actions are jeopardizing all the progress we've made. This package of bills prioritizes more criminal penalties and more enforcement, but we already ran that experiment starting back in the 1980s, and decades of escalated drug penalties did not empty the pill mills. Instead, it filled our prisons while the supply chain adapted and the deaths kept climbing.

We know what does save lives. This committee's own record shows that expanded access to medications for opioid use disorder, fentanyl test strips, and naloxone helped reduce overdose deaths by nearly 28% from 2023 to 24. That's the largest drop we've seen, and it came from treatment and harm reduction, not from a new felony. At the hearing that produced these bills, members agreed on a bipartisan basis that addiction should be treated as a disease, and that's why the Trump administration's actions to slash substance use and recovery funding could stunt the progress we've made. The Trump administration has dismantled the Substance Abuse and Mental Health Services Administration, SAMHSA, and that's the agency responsible for addressing the overdose crisis.

SAMHSA staff have been reduced by half, and the administration cut 1.7 billion in block grants for state health departments and cut 350 million in addiction and overdose prevention funding. These cuts are drastic and devastating, and if we want to truly protect our communities and win our ongoing battle against substance use disorders, we should work together to stop these attacks from the Trump administration. And with that, I yield back the balance of my time, Mr. Chairman. Thank you.

25:47 - 26:03

H. Griffith

Gentleman yields back. I would remind members that pursuant to committee rules, all members' opening statements will be made a part of the record. Are there any further opening statements? Seeing none, I now recognize... next page... I now call up H.R. 7184 and ask the clerk to report.

26:03 - 26:17

Speaker 3

H.R. 7184, a bill to amend the Controlled Substances Act to prevent the importation of illicit pill press machines with the intent to counterfeit substances and for other purposes.

26:17 - 27:42

H. Griffith

Without objection, the first reading of the bill is dispensed with and the bill will be open for amendments at any point, so ordered. Seeing no objection, and I now recognize myself for five minutes on H.R. 7184, the PRESS Act. And I offer my support for this bill with the recognition there is still work to be done on this policy and that we are engaged in bipartisan efforts to get this policy to a good place. The influx of illicit drugs into the U.S. has in part been driven by bad actors, and I would say in big part, exploiting loopholes within our legal system. Currently, one of those loopholes is the unfettered importation of pill presses and their critical parts, which are in turn being utilized for mass production of counterfeit substances.

So as many of us have heard in various testimony, they will make a pill that they then try to sell as pill X, which doesn't have much of a harm to it, but it's laced with fentanyl or some other dangerous substance, and then we have young people who are dying thinking that they're just getting a little boost for studies or something else.

So this act would give our federal prosecutors the tools they need to hold the nefarious foreign actors accountable for importing pill presses and pill equipment into the United States with the intent to illicitly produce controlled substances. I strongly urge my colleagues to support this bill and I yield back and I now recognize the gentlelady from Colorado, Ms. DeGette, the ranking member for her five minutes on the bill.

27:42 - 29:05

Diana DeGette

Thank you, Mr. Chairman. I'm really pleased to hear you say that you think this bill needs more work because it does and we look forward to working with you as it moves forward. The PRESS Act would expand DEA's jurisdiction over pill presses beyond our borders and it would make it illegal for an individual to manufacture or distribute pill press equipment if they know it will be used to manufacture illicit substances to be imported into the US. It also increases criminal penalties for listed chemicals, which are components of illicit substances or their production, and it directs the US Sentencing Commission to update sentencing guidelines, more likely than not to increase penalties. And so, like I said in my opening statement, it makes already illegal conduct more illegal.

And I worry that such increasingly punitive sentencing will not deter criminals, but it will only further overburden our judicial system. I do support making sure we can prosecute bad actors who are importing dangerous drugs into the United States. That's Energy and Commerce's part of this referral. But when the penalties are already so high, I just don't think we should increase penalties for the sake of doing it. And so I look forward to working with you and your staff on this and I yield back.

29:05 - 29:49

H. Griffith

Gentlelady yields back. Anyone else wishing to speak on the bill? Seeing none, all those in favor... hang on. Okay, the question now occurs on forwarding HR 7184 as amended to the full... not amended, but to the full committee. All those in favor say aye.

Opposed, no. The ayes have it and the bill is agreed to and forwarded to the full committee. All right, now call up HR 8005. If the clerk would report HR 8005.

29:49 - 30:03

Speaker 3

HR 8005, a bill to amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled.

30:04 - 30:19

H. Griffith

And without objection, the first reading of the bill is dispensed with and the bill will be open for amendment at any point. Seeing no objection, so ordered. And I believe that there is an amendment in the nature of a substitute at the clerk's desk. Could the clerk please report that?

30:20 - 30:25

Speaker 3

Amendment in the nature of a substitute to HR 8005 offered by Mr. Griffith of Virginia.

30:27 - 32:32

H. Griffith

And without objection, we will dispense with the reading of the amendment in the nature of a substitute. Any objection? Seeing none, I offer my support and I now recognize myself for five minutes. I offer my support to the amendment in the nature of a substitute to HR 8005, the Stop Pills that Kill Act. The AINS amendment in the nature of a substitute amends the underlying bill to clarify the scope of the legislation pertains to counterfeit pills containing fentanyl, methamphetamine, or an illicit synthetic substance.

This legislation would require the DEA to create and implement a comprehensive plan to investigate and prevent the movement of such counterfeit pills. It allows prosecutors to apply enhanced penalties to those who are involved in the manufacturing of fentanyl, fentanyl analogues, and fentanyl-related substances.

It would also require the Attorney General to conduct a report to Congress examining the collection and prosecutions of counterfeit pills that contain fentanyl, methamphetamine, or an illicit synthetic substance. This bill would give us more tools and information to prevent deadly counterfeit pills from reaching the hands of Americans, and I strongly encourage my colleagues to support this AINS and the bill. And I will tell you all that I understand that if we catch somebody doing these bad things and they've got the pills on them, it's already illegal, but I kind of equate these bills to the problem they had in Virginia in the 19th century where people were going into cemeteries and grave robbing. They couldn't always catch them with their hand in the grave, so they made it illegal to enter the cemetery after dark. Yes, if they're grave robbing, you've already got a crime, but by stopping it before they get to the grave by saying it's illegal to be in the graveyard, they solved the problem.

I think this will help solve the drug problem in the United States. It won't be a perfect cure, but I think it is one of the things that we need to do. And with that, I yield back and recognize the gentlelady of Colorado, the ranking member, Ms. DeGette, for her five minutes.

32:32 - 34:03

Diana DeGette

Thanks, Mr. Chairman. I, it's going to take me some time to think through your grave, grave robbing analysis. I'm not really sure it applies here, but let me talk about this bill because you're exactly right. If we catch them with fentanyl or fentanyl-laced substances, it's already illegal. So what this bill does, it enhances an existing criminal penalty for possession of equipment used to produce fentanyl, which or an analogue of fentanyl, or a counterfeit substance.

It also requires the DEA to establish a response plan to address counterfeit fentanyl and report to Congress on seizures and convictions under the bill. This is all at the same time DEA is struggling to enforce current laws. Now they're going to do a response plan with all of this. Look, the bill targets a real problem of the spread of counterfeit fentanyl or misrepresentation of fentanyl as another substance, but the bill misses the mark in meaningfully addressing the issue. That's because it defines counterfeit fentanyl as a substance that contains fentanyl, so the substance in question is already illegal.

And prosecutors already apply penalty enhancements for knowing misrepresentation of a drug. This bill simply duplicates existing criminal penalties. I guess silly season is approaching, and that's why I oppose this bill and I yield back.

34:04 - 34:56

H. Griffith

The gentlelady yields back. Is there further discussion on the amendment in the nature of a substitute? If there's no further discussion, the vote occurs on the amendment in the nature of the substitute. All those in favor of the amendment in the nature of the substitute shall signify by saying aye. Aye.

All those opposed, nay. The ayes have it, and the amendment is agreed to. And now we get to the bill. And the question now occurs on forwarding H.R. 8005 as amended to the full committee. All those in favor say aye.

Aye. Opposed, no. No. The ayes have it, and the bill's agreed to and forwarded to the full committee. All right.

And now H.R. 5880. I call up H.R. 5880 and ask the clerk to report.

34:56 - 35:10

Speaker 3

H.R. 5880, a bill to amend the Controlled Substances Act to require regulated persons to identify tableting machines and encapsulating machines by serial number. Be it enacted by the Senate and House of Representatives of the United States of America in Congress.

35:10 - 36:28

H. Griffith

And with that, objection, the first reading of the bill is dispensed with, and the bill will be open for amendment at any point. Seeing no objection, so ordered. And I will recognize myself for five minutes on the H.R. 5880 Fight Illicit Pill Presses Act.

I support this bill and urge all of my colleagues to do the same with the understanding that our work to fine-tune this policy will continue after today's markup and before it gets to the full committee. One of the challenges we have had with stopping the influx of illicit drugs into our community stems from our lack of ability to regulate, monitor, and track the transactions involving pill presses and their critical parts. Consequently, this limits our ability to quickly identify cases of pill presses and their critical parts as being diverted and misused for the production of illicit drugs. HR 5880, the Fight Illicit Pill Presses Act, would address this gap by mandating the serialization of pill presses and their critical parts in addition to updating the requirements to work with DEA to report and retain records of these regulated transactions, and I urge my colleagues to support this bill. And I yield back.

I now recognize ranking member, the gentlelady from Colorado, for her five minutes to discuss the bill.

36:28 - 38:22

Diana DeGette

Well, thank you, Mr. Chairman. Once again, I'm delighted to hear you say that we need to work to fine-tune this bill because this bill, again, is a really rushed-through effort, a real solution in search of a problem. This bill requires each component of a pill press to have a serial number to help law enforcement track and prosecute their uses to produce illicit drugs. I have several practical concerns with serialization and with the accompanying criminal penalties in particular. Well, here's some food for thought.

We don't even require such stringent reporting requirements and serialization for firearms. For firearms. So everyday Americans who own pill presses for non-nefarious reasons, like making supplements or even making candy, would have to comply with this law. If those individuals who are making candy at home with the presses sold a pill press without proper serialization after they were done with it, they would risk going to federal prison. Under this bill, old equipment is not grandfathered in, and there's no way to practically serialize existing equipment.

Now, I guess the response to this is prosecutors would not go after ordinary Americans. But I have to tell you, I'm a former public defender, and I really don't think we need to give the DOJ power to just go after people who are making candy in their basement. And so I think, as you do, Mr. Chairman, that this bill needs additional work. I can't understand why we're rushing through all of these bills that all need additional work and have very minimal impacts on deterring crime and fentanyl, but be that as it may, I'm going to oppose this bill too, and I yield back.

38:23 - 39:03

H. Griffith

Gentlelady yields back. Anyone else wish to be recognized to discuss the bill? All right. The question, seeing none, then the question now occurs on forwarding HR 5880 to the full committee. All those in favor say aye.

Opposed, no. Two to one. The ayes have it, and the bill's agreed to and forwarded to the full committee. All right. Without objection, staff is authorized to make technical and conforming changes to the legislation approved by the committee today.

Without objection, so ordered. And the committee stands adjourned for a minute or two.

U.S. House of Representatives

Follow upcoming sessions live, transcribed word for word, with AI chat

One free trial opens the AI chat on every session, the biographies of your parliament's members, alerts, and your questions to Claude or ChatGPT.

  • Live transcript, every speaker identified
  • The biography of every member of your parliament, with its assistant
  • Alerts on your keywords, and your questions to Claude or ChatGPT

Every video is free to watch, live and on replay, no account needed.

14-day free trial · cancel anytime

Free trial Learn more

Already have an account? Log in

Keyboard shortcuts

Playback

Play / pause
Space
Back / forward 15 s
←→
Back / forward 10 s
JL
Full screen
F

Chapters and transcript

Previous / next chapter
PN
Search the transcript
/
Turn follow on / off
S
Copy the current sentence as a quote
C
Show this help
?

Inactive while a text field, a button or the chat has focus.